Living definition
What is Fujirebio Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio Test?
Medical Imaging & Diagnostics Bio, Health & Neuro
- As of
- 2026-07-27
- Revision
- 2026-07-28.1
- Method
- v1.3.0
Definition
The term, in context
AI-assisted draft · approved dataset
The Fujirebio Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio Test is a blood-based diagnostic assay that measures the ratio of phosphorylated tau 217 protein to amyloid-beta 42 protein in a patient's blood plasma using automated immunoassay chemistry, providing a less invasive alternative to PET scans or cerebrospinal fluid testing for detecting amyloid pathology associated with Alzheimer's disease.
Live readiness status
Status as of the current dateline
AI-assisted assembly · derived results
As of 2026-07-27, verified readiness is 57 (claimed 90, reported 72, gap 33) — Growing evidence strength; current signals suggest Proceed with caution.
The readiness fact belongs to the canonical Readiness Verdict for Fujirebio Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio Test.
Dataset approval
Human editorial release
pragma.vision editorial — standing authorization (operator dev@soft.house, 2026-07-17)
- Dataset
- 2026-07-28.1
- Hash
- sha256:02aa1ee2b9f805eacafe59552c1be4a62ac3e0edb8374314ff1adcfa3147c32f
- Approved
- 2026-07-28